Essentials of pharmaceutical preformulation:
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Chichester, West Sussex
Wiley-Blackwell
2013
|
Schlagworte: | |
Beschreibung: | Online-Ausg. 2012 erschienen |
Beschreibung: | XVI, 252 S. Ill., graph. Darst. |
ISBN: | 9780470976357 9780470976364 9781118423189 9781118423240 |
Internformat
MARC
LEADER | 00000nam a2200000zc 4500 | ||
---|---|---|---|
001 | BV042977759 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 151104s2013 ad|| |||| 00||| eng d | ||
020 | |a 9780470976357 |c Print |9 978-0-470-97635-7 | ||
020 | |a 9780470976364 |c paper |9 978-0-470-97636-4 | ||
020 | |a 9781118423189 |9 978-1-118-42318-9 | ||
020 | |a 9781118423240 |9 978-1-118-42324-0 | ||
035 | |a (OCoLC)840883516 | ||
035 | |a (DE-599)BVBBV042977759 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-19 | ||
082 | 0 | |a 615.1/9 |2 23 | |
084 | |a VX 5200 |0 (DE-625)147798:253 |2 rvk | ||
100 | 1 | |a Gaisford, Simon |e Verfasser |4 aut | |
245 | 1 | 0 | |a Essentials of pharmaceutical preformulation |c Simon Gaisford ; Mark Saunders |
264 | 1 | |a Chichester, West Sussex |b Wiley-Blackwell |c 2013 | |
300 | |a XVI, 252 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
500 | |a Online-Ausg. 2012 erschienen | ||
505 | 0 | |a Basic principles of preformulation studies -- Ionisation constants -- Partitioning affinity -- Solubility -- Dissolution -- Salt selection -- Physical form I : crystalline materials -- Physical form II : amorphous materials -- Stability assessment -- Particle properties -- Powder properties | |
650 | 4 | |a Drug Compounding / methods | |
650 | 4 | |a Drug Discovery / methods | |
650 | 7 | |a MEDICAL / Drug Guides |2 bisacsh | |
650 | 7 | |a MEDICAL / Nursing / Pharmacology |2 bisacsh | |
650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
650 | 7 | |a MEDICAL / Pharmacy |2 bisacsh | |
650 | 4 | |a Medizin | |
650 | 4 | |a Drugs / Design / Methodology | |
650 | 0 | 7 | |a Arzneiform |0 (DE-588)4068874-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Formulierung |g Technische Chemie |0 (DE-588)4246877-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |D s |
689 | 0 | 1 | |a Arzneiform |0 (DE-588)4068874-4 |D s |
689 | 0 | 2 | |a Formulierung |g Technische Chemie |0 (DE-588)4246877-2 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Saunders, Mark |d 1959- |e Verfasser |0 (DE-588)132134411 |4 aut | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-118-42321-9 |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-118-42322-6 |
999 | |a oai:aleph.bib-bvb.de:BVB01-028403358 |
Datensatz im Suchindex
_version_ | 1804175311129018368 |
---|---|
any_adam_object | |
author | Gaisford, Simon Saunders, Mark 1959- |
author_GND | (DE-588)132134411 |
author_facet | Gaisford, Simon Saunders, Mark 1959- |
author_role | aut aut |
author_sort | Gaisford, Simon |
author_variant | s g sg m s ms |
building | Verbundindex |
bvnumber | BV042977759 |
classification_rvk | VX 5200 |
contents | Basic principles of preformulation studies -- Ionisation constants -- Partitioning affinity -- Solubility -- Dissolution -- Salt selection -- Physical form I : crystalline materials -- Physical form II : amorphous materials -- Stability assessment -- Particle properties -- Powder properties |
ctrlnum | (OCoLC)840883516 (DE-599)BVBBV042977759 |
dewey-full | 615.1/9 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.1/9 |
dewey-search | 615.1/9 |
dewey-sort | 3615.1 19 |
dewey-tens | 610 - Medicine and health |
discipline | Chemie / Pharmazie Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02341nam a2200553zc 4500</leader><controlfield tag="001">BV042977759</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">151104s2013 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470976357</subfield><subfield code="c">Print</subfield><subfield code="9">978-0-470-97635-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470976364</subfield><subfield code="c">paper</subfield><subfield code="9">978-0-470-97636-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118423189</subfield><subfield code="9">978-1-118-42318-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118423240</subfield><subfield code="9">978-1-118-42324-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)840883516</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042977759</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.1/9</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 5200</subfield><subfield code="0">(DE-625)147798:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gaisford, Simon</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Essentials of pharmaceutical preformulation</subfield><subfield code="c">Simon Gaisford ; Mark Saunders</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chichester, West Sussex</subfield><subfield code="b">Wiley-Blackwell</subfield><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVI, 252 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Online-Ausg. 2012 erschienen</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Basic principles of preformulation studies -- Ionisation constants -- Partitioning affinity -- Solubility -- Dissolution -- Salt selection -- Physical form I : crystalline materials -- Physical form II : amorphous materials -- Stability assessment -- Particle properties -- Powder properties</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Compounding / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Discovery / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Drug Guides</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Nursing / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacy</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Design / Methodology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneiform</subfield><subfield code="0">(DE-588)4068874-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Formulierung</subfield><subfield code="g">Technische Chemie</subfield><subfield code="0">(DE-588)4246877-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneiform</subfield><subfield code="0">(DE-588)4068874-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Formulierung</subfield><subfield code="g">Technische Chemie</subfield><subfield code="0">(DE-588)4246877-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saunders, Mark</subfield><subfield code="d">1959-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)132134411</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-118-42321-9</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-118-42322-6</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028403358</subfield></datafield></record></collection> |
id | DE-604.BV042977759 |
illustrated | Illustrated |
indexdate | 2024-07-10T07:14:16Z |
institution | BVB |
isbn | 9780470976357 9780470976364 9781118423189 9781118423240 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028403358 |
oclc_num | 840883516 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM |
owner_facet | DE-19 DE-BY-UBM |
physical | XVI, 252 S. Ill., graph. Darst. |
publishDate | 2013 |
publishDateSearch | 2013 |
publishDateSort | 2013 |
publisher | Wiley-Blackwell |
record_format | marc |
spelling | Gaisford, Simon Verfasser aut Essentials of pharmaceutical preformulation Simon Gaisford ; Mark Saunders Chichester, West Sussex Wiley-Blackwell 2013 XVI, 252 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Online-Ausg. 2012 erschienen Basic principles of preformulation studies -- Ionisation constants -- Partitioning affinity -- Solubility -- Dissolution -- Salt selection -- Physical form I : crystalline materials -- Physical form II : amorphous materials -- Stability assessment -- Particle properties -- Powder properties Drug Compounding / methods Drug Discovery / methods MEDICAL / Drug Guides bisacsh MEDICAL / Nursing / Pharmacology bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh Medizin Drugs / Design / Methodology Arzneiform (DE-588)4068874-4 gnd rswk-swf Formulierung Technische Chemie (DE-588)4246877-2 gnd rswk-swf Pharmazeutische Technologie (DE-588)4045699-7 gnd rswk-swf Pharmazeutische Technologie (DE-588)4045699-7 s Arzneiform (DE-588)4068874-4 s Formulierung Technische Chemie (DE-588)4246877-2 s DE-604 Saunders, Mark 1959- Verfasser (DE-588)132134411 aut Erscheint auch als Online-Ausgabe 978-1-118-42321-9 Erscheint auch als Online-Ausgabe 978-1-118-42322-6 |
spellingShingle | Gaisford, Simon Saunders, Mark 1959- Essentials of pharmaceutical preformulation Basic principles of preformulation studies -- Ionisation constants -- Partitioning affinity -- Solubility -- Dissolution -- Salt selection -- Physical form I : crystalline materials -- Physical form II : amorphous materials -- Stability assessment -- Particle properties -- Powder properties Drug Compounding / methods Drug Discovery / methods MEDICAL / Drug Guides bisacsh MEDICAL / Nursing / Pharmacology bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh Medizin Drugs / Design / Methodology Arzneiform (DE-588)4068874-4 gnd Formulierung Technische Chemie (DE-588)4246877-2 gnd Pharmazeutische Technologie (DE-588)4045699-7 gnd |
subject_GND | (DE-588)4068874-4 (DE-588)4246877-2 (DE-588)4045699-7 |
title | Essentials of pharmaceutical preformulation |
title_auth | Essentials of pharmaceutical preformulation |
title_exact_search | Essentials of pharmaceutical preformulation |
title_full | Essentials of pharmaceutical preformulation Simon Gaisford ; Mark Saunders |
title_fullStr | Essentials of pharmaceutical preformulation Simon Gaisford ; Mark Saunders |
title_full_unstemmed | Essentials of pharmaceutical preformulation Simon Gaisford ; Mark Saunders |
title_short | Essentials of pharmaceutical preformulation |
title_sort | essentials of pharmaceutical preformulation |
topic | Drug Compounding / methods Drug Discovery / methods MEDICAL / Drug Guides bisacsh MEDICAL / Nursing / Pharmacology bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh Medizin Drugs / Design / Methodology Arzneiform (DE-588)4068874-4 gnd Formulierung Technische Chemie (DE-588)4246877-2 gnd Pharmazeutische Technologie (DE-588)4045699-7 gnd |
topic_facet | Drug Compounding / methods Drug Discovery / methods MEDICAL / Drug Guides MEDICAL / Nursing / Pharmacology MEDICAL / Pharmacology MEDICAL / Pharmacy Medizin Drugs / Design / Methodology Arzneiform Formulierung Technische Chemie Pharmazeutische Technologie |
work_keys_str_mv | AT gaisfordsimon essentialsofpharmaceuticalpreformulation AT saundersmark essentialsofpharmaceuticalpreformulation |